新型冠状病毒肺炎合并肥胖症的评估与治疗策略Evaluation and Treatment of Coronavirus Disease 2019 with Obesity
王诗蕊;陈适;朱惠娟;
WANG Shi-rui;CHEN Shi;ZHU Hui-juan;Chinese Academy of Medical Sciences & Peking Union Medical College;Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College;
摘要(Abstract):
新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)已成为危及全球的传染性疾病,重症患者死亡风险极高。临床研究显示,肥胖症是COVID-19患者发生重症及死亡的独立危险因素。对于合并肥胖症的COVID-19患者,应尽早评估肥胖相关合并症,并在营养、气道管理、抗凝、合并症控制等方面采取更积极的干预措施,以改善预后。
The pandemic of coronavirus disease 2019(COVID-19) has spread worldwide and the mortality is high in severe COVID-19 patients. Clinical studies suggested that obesity is an independent risk factor for severe and dead cases of COVID-19. For COVID-19 patients with obesity, early evaluation of obesity-related comorbidities and aggressive treatments, including diet control, airway management, anticoagulant thromboprophylaxis, and management of comorbidities, are encouraged to improve their prognosis.
关键词(KeyWords):
新型冠状病毒肺炎;肥胖症;评估;治疗
coronavirus disease 2019;obesity;evaluation;treatment
基金项目(Foundation): 中国医学科学院医学与健康科技创新工程(2016-I2M-1-002)~~
作者(Author):
王诗蕊;陈适;朱惠娟;
WANG Shi-rui;CHEN Shi;ZHU Hui-juan;Chinese Academy of Medical Sciences & Peking Union Medical College;Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College;
Email:
DOI:
参考文献(References):
- [1] Guan WJ,Ni ZY,Hu Y,et al.Clinical Characteristics of Coronavirus Disease 2019 in China[J].N Engl J Med,2020,382:1708- 1720.
- [2] Global Health Obsevatory (GHO) data:overweight and obesity[EB/OL].https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
- [3] Huang Y,Lu Y,Huang YM,et al.Obesity in patients with COVID- 19:a systematic review and meta-analysis[J].Metabolism,2020,113:154378.
- [4] Hussain A,Mahawar K,Xia Z,et al.Obesity and mortality of COVID- 19.Meta-analysis[J].Obes Res Clin Pract,2020,14:295- 300.
- [5] Du Y,Lv Y,Zha W,et al.Association of Body mass index (BMI) with Critical COVID- 19 and in-hospital Mortality:a dose-response meta-analysis[J].Metabolism,2020.doi:10.1016/j.metabol.2020.154373:154373.
- [6] Cai Q,Chen F,Wang T,et al.Obesity and COVID- 19 Severity in a Designated Hospital in Shenzhen,China[J].Diabetes Care,2020,43:1392- 1398.
- [7] Soeroto AY,Soetedjo NN,Purwiga A,et al.Effect of increased BMI and obesity on the outcome of COVID- 19 adult patients:A systematic review and meta-analysis[J].Diabetes Metab Syndr,2020,14:1897- 1904.
- [8] F?ldi M,Farkas N,Kiss S,et al.Obesity is a risk factor for developing critical condition in COVID- 19 patients:A systematic review and meta-analysis[J].Obes Rev,2020,21:e13095.
- [9] Seidu S,Gillies C,Zaccardi F,et al.The impact of obesity on severe disease and mortality in people with SARS-CoV- 2:A systematic review and meta-analysis[J].Endocrinol Diabetes Metab,2020.doi:10.1002/edm2.176:e00176.
- [10] Sattar N,McInnes IB,McMurray JJV.Obesity Is a Risk Factor for Severe COVID- 19 Infection:Multiple Potential Mechanisms[J].Circulation,2020,142:4- 6.
- [11] Nakeshbandi M,Maini R,Daniel P,et al.The impact of obesity on COVID- 19 complications:a retrospective cohort study[J].Int J Obes (Lond),2020,44:1832- 1837.
- [12] Tsuriya D,Morita H,Morioka T,et al.Significant correla-tion between visceral adiposity and high-sensitivity C-reactive protein (hs-CRP) in Japanese subjects[J].Intern Med,2011,50:2767- 2773.
- [13] Noor FM,Islam MM.Prevalence and Associated Risk Factors of Mortality Among COVID- 19 Patients:A Meta-Analysis[J].J Community Health,2020,45:1270- 1282.
- [14] Chen C,Lu FC.The guidelines for prevention and control of overweight and obesity in Chinese adults[J].Biomed Environ Sci,2004,17 Suppl:1- 36.
- [15] Tchernof A,Després JP.Pathophysiology of human visceral obesity:an update[J].Physiol Rev,2013,93:359- 404.
- [16] Sharma AM,Kushner RF.A proposed clinical staging system for obesity[J].Int J Obes (Lond),2009,33:289- 295.
- [17] Petersen A,Bressem K,Albrecht J,et al.The role of visceral adiposity in the severity of COVID- 19:Highlights from a unicenter cross-sectional pilot study in Germany[J].Metabolism,2020,110:154317.
- [18] Chiappetta S,Sharma AM,Bottino V,et al.COVID- 19 and the role of chronic inflammation in patients with obesity[J].Int J Obes (Lond),2020,44:1790- 1792.
- [19] Ye Q,Wang B,Mao J.The pathogenesis and treatment of the `Cytokine Storm' in COVID- 19[J].J Infect,2020,80:607- 613.
- [20] Watanabe M,Caruso D,Tuccinardi D,et al.Visceral fat shows the strongest association with the need of intensive Care in Patients with COVID- 19[J].Metabolism,2020,111:154319.
- [21] Yang Y,Ding L,Zou X,et al.Visceral Adiposity and High Intramuscular Fat Deposition Independently Predict Critical Illness in Patients with SARS-CoV- 2[J].Obesity (Silver Spring),2020,28:2040- 2048.
- [22] Dixon AE,Peters U.The effect of obesity on lung function[J].Expert Rev Respir Med,2018,12:755- 767.
- [23] Memtsoudis SG,Ivascu NS,Pryor KO,et al.Obesity as a risk factor for poor outcome in COVID- 19-induced lung injury:the potential role of undiagnosed obstructive sleep apnoea[J].Br J Anaesth,2020,125:e262-e263.
- [24] Guo T,Fan Y,Chen M,et al.Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID- 19)[J].JAMA Cardiol,2020,5:811- 818.
- [25] Shi S,Qin M,Shen B,et al.Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID- 19 in Wuhan,China[J].JAMA Cardiol,2020,5:802- 810.
- [26] Ghoneim S,Butt MU,Hamid O,et al.The incidence of COVID- 19 in patients with metabolic syndrome and non-alcoholic steatohepatitis:A population-based study[J].Metabol Open,2020,8:100057.
- [27] Iqbal Z,Ho JH,Adam S,et al.Managing hyperlipidaemia in patients with COVID- 19 and during its pandemic:An expert panel position statement from HEART UK[J].Atherosclerosis,2020,313:126- 136.
- [28] Fernández García L,Puentes Gutiérrez AB,García Bascones M.Relationship between obesity,diabetes and ICU admis-sion in COVID- 19 patients[J].Med Clin (Engl Ed),2020,155:314- 315.
- [29] Ochoa JB,Cárdenas D,Goiburu ME,et al.Lessons Learned in Nutrition Therapy in Patients With Severe COVID- 19[J].JPEN J Parenter Enteral Nutr,2020,44:1369- 1375.
- [30] Helms J,Tacquard C,Severac F,et al.High risk of thrombosis in patients with severe SARS-CoV- 2 infection:a multicenter prospective cohort study[J].Intensive Care Med,2020,46:1089- 1098.
- [31] Moores LK,Tritschler T,Brosnahan S,et al.Prevention,Diagnosis,and Treatment of VTE in Patients With Coronavirus Disease 2019:CHEST Guideline and Expert Panel Report[J].Chest,2020,158:1143- 1163.
- [32] Mauvais-Jarvis F.Aging,Male Sex,Obesity,and Metabolic Inflammation Create the Perfect Storm for COVID- 19[J].Diabetes,2020,69:1857- 1863.
- [33] Bornstein SR,Rubino F,Khunti K,et al.Practical recommendations for the management of diabetes in patients with COVID- 19[J].Lancet Diabetes Endocrinol,2020,8:546- 550.
- [34] Roche provides an update on the phase Ⅲ COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID- 19 associated pneumonia[EB/OL].(2020- 07- 29).https://www.roche.com/investors/updates/inv-update- 2020- 07- 29.htm.
- [35] Huang JF,Wang XB,Zheng KI,et al.Letter to the Editor:Obesity hypoventilation syndrome and severe COVID-19[J].Metabolism,2020,108:154249.
- [36] Singer P,Blaser AR,Berger MM,et al.ESPEN guideline on clinical nutrition in the intensive care unit[J].Clin Nutr,2019,38:48- 79.
- [37] Wijaya I,Andhika R,Huang I.Hypercoagulable state in COVID- 19 with diabetes mellitus and obesity:Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?[J].Diabetes Metab Syndr,2020,14:1241- 1242.
- [38] Susen S,Tacquard CA,Godon A,et al.Prevention of thrombotic risk in hospitalized patients with COVID- 19 and hemostasis monitoring[J].Critical Care,2020,24:364.
- [39] Marini JJ,Gattinoni L.Management of COVID-19 Respira-tory Distress[J].JAMA,2020,323:2329- 2330.
- [40] De Jong A,Wrigge H,Hedenstierna G,et al.How to ventilate obese patients in the ICU[J].Intensive Care Med,2020,46:2423- 2435.
- [41] Lemyze M,Courageux N,Maladobry T,et al.Implications of Obesity for the Management of Severe Coronavirus Disease 2019 Pneumonia[J].Crit Care Med,2020,48:e761-e767.
- [42] Moriconi D,Masi S,Rebelos E,et al.Obesity prolongs the hospital stay in patients affected by COVID- 19,and may impact on SARS-COV- 2 shedding[J].Obes Res Clin Pract,2020,14:205- 209.
- [43] Katulanda P,Dissanayake HA,Ranathunga I,et al.Prevention and management of COVID- 19 among patients with diabetes:an appraisal of the literature[J].Diabetologia,2020,63:1440- 1452.
- 王诗蕊
- 陈适
- 朱惠娟
WANG Shi-rui- CHEN Shi
- ZHU Hui-juan
- Chinese Academy of Medical Sciences & Peking Union Medical College
- Department of Endocrinology
- Key Laboratory of Endocrinology
- National Health Commission of the People's Republic of China
- Peking Union Medical College Hospital
- Chinese Academy of Medical Sciences & Peking Union Medical College
- 王诗蕊
- 陈适
- 朱惠娟
WANG Shi-rui- CHEN Shi
- ZHU Hui-juan
- Chinese Academy of Medical Sciences & Peking Union Medical College
- Department of Endocrinology
- Key Laboratory of Endocrinology
- National Health Commission of the People's Republic of China
- Peking Union Medical College Hospital
- Chinese Academy of Medical Sciences & Peking Union Medical College